According to the latest market research study published by P&S Intelligence, the global magnetoencephalography market is on an impressive growth trajectory. Valued at USD 307.9 million in 2024, it is projected to surge to USD 470.7 million by 2032, advancing at a steady CAGR of 5.6% from 2025 to 2032.
This growth is fueled by advancements in neuroimaging technologies, the increasing prevalence of neurological disorders, and the rising demand for non-invasive diagnostic techniques. With the world’s aging population expanding rapidly, MEG technology is emerging as a critical tool for early diagnosis, treatment planning, and research into brain-related conditions.
MEG’s Clinical Impact: Unlocking Precision in Brain Diagnostics
Magnetoencephalography has proven highly effective in detecting conditions such as epilepsy, dementia, brain tumors, multiple sclerosis, and stroke. Unlike other diagnostic tools, MEG directly captures signals from neuronal electrical activity with exceptional sensitivity, enabling precise detection of abnormalities in brain regions such as the lateral temporal neocortex and superficial frontal cortex.
Stress-related lifestyle diseases such as insomnia, mood disorders, heart disease, and obesity are also contributing to demand for MEG, as these tests aid in identifying underlying neurological factors with unmatched accuracy.
Key Growth Drivers & Technological Advancements
- Next-gen OPM-based MEG systems operate at room temperature, eliminating bulky cryogenic coolers and making devices more compact, wearable, and portable.
- AI and machine learning integration is enabling enhanced data analysis, uncovering hidden patterns and abnormalities.
- Telemedicine adoption allows remote access to MEG data, enhancing global collaboration and care delivery.
- Enhanced background noise cancellation and motion detection are improving diagnostic precision.
- Real-time monitoring functions now support intraoperative applications such as neurofeedback and brain–computer interfaces.
Governments and institutions are recognizing MEG’s transformative potential. For instance, the Indian government allocated INR 20,000 crore in 2025 to deep-tech research, indirectly boosting neuroimaging innovation. Similarly, Cerca Magnetics Limited secured a GBP 1.3 million grant to develop wearable MEG systems for pediatric epilepsy diagnosis.
Rising Neurological Disease Burden Accelerates Demand
The global prevalence of neurological disorders is reaching alarming levels. According to the WHO, around 50 million people suffer from epilepsy, and nearly 10 million new dementia cases are diagnosed each year. Alzheimer’s Disease International projects that 139 million people will live with dementia by 2050, underscoring the urgent need for advanced diagnostic solutions.
MEG is increasingly adopted in both clinical and research settings to improve early detection, guide surgical planning, and advance neuroscience studies under global initiatives such as the U.S. BRAIN Initiative and European Human Brain Project.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/magnetoencephalography-market/report-sample
Market Segmentation Highlights
- By Type:
- Superconducting Quantum Interference Devices (SQUIDs) held 70% share in 2024, driven by superior spatial resolution.
- Optically Pumped Magnetometers (OPMs) will witness faster growth due to portability, affordability, and real-time adaptability.
- By Application:
- Clinical segment held 65% share in 2024, led by epilepsy diagnostics.
- Research segment will grow at the highest CAGR, powered by neuroscience breakthroughs and academic adoption.
- By End User:
- Hospitals dominate with 45% share in 2024, supported by infrastructure and patient volume.
- Academic & research institutes are the fastest-growing due to government funding and international collaborations.
Regional Insights
- North America leads the global market with 40% share in 2024 and is projected to grow at the fastest CAGR of 6% through 2032, supported by high healthcare spending, strong reimbursement policies, and rapid adoption of next-gen technologies.
- Europe and Asia-Pacific are also major contributors, with Germany, the U.K., China, and India driving regional growth through innovation and rising patient populations.
Competitive Landscape
The MEG market remains consolidated, with high technological entry barriers. Key players include Compumedics Limited, MEGIN, FieldLine Inc., Cerca Magnetics Limited, Ricoh USA, Siemens Healthineers, Philips Healthcare, GE Healthcare, and Nihon Kohden Corporation.
Notably, in May 2025, Compumedics Limited partnered with Beijing Fistar and TJNU for MEG recordings across age groups, while the University of Alabama at Birmingham upgraded its MEG systems in November 2024 to strengthen epilepsy and brain disorder research.